6Efferth A,Dunstan H,Sauerbrey A,et al.The antimalarial artesunate is also active against cancer[J].Int J Oncol,2001,18 (4):767.
7Singh NP,Lai H.Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells[J].Life scisnces,2001,70(1):49-56.
8Lai H,Singh N P.Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin[J].Cancer Lett,1995,91(4):41-46.
9Mooce JC,Lai H,Li JR,et al.Oraladministration of dihydroartemisinin and ferroussulfate retarded implanted fibrosarcoma growth in the therat[J].CancerLett,1995,98 (1):83-87.
10Lai H,Sasak T,Singh NP,et al.Effects of artemisinin-tagged holotransferrion cancer cells[J].Life Sci,2005,76 (11):1267.
6[1]Woerdenbag HJ, Moskal TA, Pras N, Malingre TM, el-Feraly FS, Kampinga HH, et al. Cytotoxicity of arte misinin-related endoperoxides to Ehrlich ascites tumor cells [J]. J Nat Prod,1993; 56(6): 849- 56
7[3]Li Y, Shan F, Wu JM, Wu GS, Ding J, Xiao D, et al. Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle[J]. Bioorg Med Chem Lett, 2001;11(1):5- 8
8[7]Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells[J]. Life Sciences, 2001;70(1):49- 56
9[8]Moore JC, Lai H, Li JR, Ren RL, McDougall JA, Singh NP,et al. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat[J]. Cancer Lett, 1995;98(1):83- 7
10[9]Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin [J]. Cancer Lett,1995;91(1) :41 - 6
